COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
USA117th CongressHR-5745| House
| Updated: 10/28/2021
Neal P. Dunn
Republican Representative
Florida
Cosponsors (2)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresAgingCardiovascular and respiratory healthCell biology and embryologyChild healthDepartment of Health and Human ServicesEmergency medical services and trauma careImmunology and vaccinationInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsMedicareResearch administration and funding
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
USA117th CongressHR-5745| House
| Updated: 10/28/2021
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Neal P. Dunn
Republican Representative
Florida
Cosponsors (2)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresAgingCardiovascular and respiratory healthCell biology and embryologyChild healthDepartment of Health and Human ServicesEmergency medical services and trauma careImmunology and vaccinationInfectious and parasitic diseasesMedical researchMedical tests and diagnostic methodsMedicareResearch administration and funding